- Home
- RNAZ vs FSP Comparison
RNAZ vs FSP Comparison
Compare RNAZ & FSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RNAZ | FSP |
|---|---|---|
| Founded | 2016 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.9M | 33.3M |
| IPO Year | 2021 | 2001 |
Fundamental Metrics
Financial Performance| Metric | RNAZ | FSP |
|---|---|---|
| Price | $1.80 | $0.40 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 50.3K | ★ 1.1M |
| Earning Date | 08-14-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 2.50% |
| EPS Growth | N/A | ★ 15.69 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $107,162,000.00 |
| Revenue This Year | N/A | $16.75 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.52 | $0.30 |
| 52 Week High | $15.33 | $1.43 |
Technical Indicators
Market Signals| Indicator | RNAZ | FSP |
|---|---|---|
| Relative Strength Index (RSI) | 45.70 | 59.86 |
| Support Level | $1.55 | $0.40 |
| Resistance Level | $2.39 | $0.51 |
| Average True Range (ATR) | 0.17 | 0.02 |
| MACD | 0.08 | 0.01 |
| Stochastic Oscillator | 68.29 | 90.69 |
Price Performance
Historical ComparisonAbout RNAZ TransCode Therapeutics Inc.
TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.
About FSP Franklin Street Properties Corp.
Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The principal revenue sources for its real estate operations include rental income from real estate leasing, property dispositions and fee income from asset/property management and development. The company provides asset management, property management, property accounting, investor and/or development services to its portfolio and Sponsored REIT through the company's subsidiaries.